New guidelines will help doctors recognize and treat children at risk of venous thromboembolism.
A new study looks at outcomes for children with leukemia when two tests of remission disagree.
Some subtypes of leukemia have a poor prognosis. Genomic studies are helping to identify these subtypes, leading to targeted therapies.
Understanding the “Three C’s” may provide the insights need to move the needle on the cancers with the bleakest prognoses.
When a result provides questionable or limited clinical utility, physicians and genetic counselors must educate patients and providers on the pros and cons of genetic testing.
New regimen offers a promising approach for unrelated donor transplants.
Characterization of GGAA-microsatellites provides insight in the role of noncoding DNA in cancer susceptibility and therapeutic development.
